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Purpose. Muscle pain is a natural consequence of intense and prolonged exercise and has been 
suggested to be a limiter of performance. Transcutaneous electrical nerve stimulation (TENS) 
and interferential current (IFC) have been shown to reduce both chronic and acute pain in a 
variety of conditions. This study sought to ascertain whether TENS and IFC could reduce 
exercise-induced pain (EIP) and whether this would affect exercise performance. It was 
hypothesised that TENS and IFC would reduce EIP and result in an improved exercise 
performance.  
Methods. In two parts, 18 (Part I) and 22 (Part II) healthy male and female participants 
completed an isometric contraction of the dominant bicep until exhaustion (Part I) and a 16.1 
km cycling time trial as quickly as they could (Part II) whilst receiving TENS, IFC and a SHAM 
placebo in a repeated measures, randomized cross-over, and placebo controlled design. 
Perceived EIP was recorded in both tasks using a validated subjective scale.  
Results. In Part I, TENS significantly reduced perceived EIP (mean reduction of 12%) during 
the isometric contraction (P = 0.006 DQG VLJQLILFDQWO\ LPSURYHG SDUWLFLSDQWV¶ WLPH WR
exhaustion by a mean of 38% (P = 0.02). In Part II, TENS significantly improved (P = 0.003) 
SDUWLFLSDQWV¶WLPHWULDOFRPSOHWLRQWLPHaLPSURYHPHQWWKURXJKDQLQFUHDVHGmean power 
output.  
Conclusion. These findings demonstrate that TENS can attenuate perceived EIP in a healthy 
population and that doing so significantly improves endurance performance in both 
submaximal isometric single limb exercise and whole-body dynamic exercise. 
 









EIP, exercise-induced pain; ANOVA, analysis of variance; PO, power output; HR, heart rate; 
B[La], blood lactate; MVC maximal voluntary contraction; RPE, ratings of perceived exertion; 
TENS, transcutaneous electrical nerve stimulation; IFC, interferential current; TTE, time to 
exhaustion test; Hz, hertz; GXT, graded exercise test; TT, time trial completion time; BRUMS, 




Exercise-induced muscle pain (EIP) arises from an accumulation of endogenous algesic 
substances and an increase in intramuscular pressure (Cook et al. 1997). These endogenous 
algesics are released from cells when homoeostasis is disturbed as a consequence of intense 
exercise (Mauger et al. 2010). Therefore, EIP is closely bound to both the intensity and duration 
of the exercise task (Cook et al. 1997).  It is suggested that the perceived pain arising from 
exercise may play a combined role in the regulation of the level of exercise intensity and 
preservation of a metabolic reserve by the central nervous system (Mauger, 2014). However, 
the means by which this may occur is complex, and likely involves both physiological and 
psychological mechanisms. Indeed, increased activity of afferent fibres, which are stimulated 
by muscle nociceptors, can reduce maximal voluntary contraction of a muscle (GravenǦNielsen 
et al. 2002, Kennedy et al. 2013) and could reduce exercise performance through a reduction 
in voluntary activation (Kennedy et al. 2013). Thus, muscle pain may increase afferent neuron 
inhibition and obstruct or alter the ability of the brain to recruit muscle to produce force 
(GravenǦNielsen et al. 2002), which would ultimately contribute to fatigue and a decreased task 
performance. In addition to this, perceived pain provides a powerful psychological stimulus to 
disengage with the behaviour or action that is causing it. As EIP increases linearly with exercise 
intensity, it is suggested that intolerable EIP may influence decisions to reduce work rate (in 
order to reduce pain), or disengage with the exercise task (Kress and Stratler, 2007, Mauger, 
2014). In both these instances, an impeded endurance performance will be the result. In support 
this notion, individuals who are willing to tolerate more pain demonstrate superior endurance 
performances than those who are not (Astokorki and Mauger, 2016), and reducing pain during 
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exercise can result in an improved endurance performance (Mauger et al. 2010, Foster et al, 
2014).  
Transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC) have been 
shown to elicit analgesic effects in a variety of conditions (Marchand et al. 1993; Robinson, 
1996; Salisbury & Johnson, 1997). The neurophysiological basis of muscle pain relief from 
TENS is believed to derive directly from the gate control theory of pain. +HUHLWLVVXJJHVWHG
WKDWQRQnociceptive afferent fibres activate interneurons at the spinal cord level whichLQKLELW
WKH DFWLYLW\ RI nociceptive projection neurons, thus blunting nociceptive input from the 
peripheral tissues. Accordingly, TENS is proposed to VHOHFWLYHO\DFWLYDWH$ȕODUJH-diameter 
afferent fibres by high frequency stimulation, inhibiting constant transmission of nociceptive 
neurons by generating an afferent barrage of nerve impulses within the spinal cord (Melzack 
& Wall, 1967). It is also suggested that the application of TENS burst mode can lead to the 
release of endogenous opioids, and serotonin and a subsequent decrease in muscle pain (Sabino 
et al. 2008). IFC utilises a medium frequency alternating current with a various beat frequency 
(Gomes et al. 2014), which is believed to reduce pain transmission through gate control 
mechanisms, release endorphins and increase circulation of opioids (Melzack & Wall, 1967). 
Muscle stimulation using therapeutic current has previously been used in combination with 
exercise to achieve a variety of effects, including facilitated recovery and relief from delayed 
onset muscle soreness (Heyman, 2009; Vanderthommen et al. 2012). Given that EIP may be a 
factor affecting exercise capacity and performance, and that therapeutic muscle stimulation has 
shown promise in the treatment of muscle pain (Tourville etal. 2006), there may be scope to 
use this technique to reduce naturally occurring muscle pain during exercise.  
No studies have considered the effectiveness of TENS and IFC on EIP during fatiguing 
exercise. Therefore, the aim of this study was to investigate whether TENS or IFC elicit an 
analgesic effect during exercise, and whether this would improve endurance exercise 
performance. It was hypothesised that TENS and IFC would reduce perceived EIP, assessed 







Participants and experimental design:  Prior to participation in either Parts (Part I and Part II) 
of this study, an information sheet was given to participants, which included an 
inclusion/exclusion criteria checklist. Participants were excluded from the study if they had 
history of cardiovascular disorders (e.g. angina, heart attack, high blood pressure etc.), chronic 
medications that affect the central nervous system, current pregnancy, bleeding disorders (e.g. 
haemophilia), deep vein thrombosis, impaired sensation, acute/chronic infection (e.g. 
tuberculosis), malignancy, recently radiated tissue, skin diseases or severely damaged skin, 
types I or II diabetes, were using a cochlear implant hearing device or pacemakers, or any other 
condition that may be a danger to their participation (e.g. muscle injury). Following satisfactory 
completion of the inclusion/exclusion criteria checklist, all participants provided written 
informed consent and the research was approved by the University Ethics Committee 
(Reference Number: Prop 69_2014_2015 and Prop 146-2014_2015). Prior to all experimental 
occasions, participants were asked to refrain from the ingestion of alcohol 48 h before the 
laboratory visits, and asked to refrain from any vigorous exercise (24 h prior), caffeine (8 h 
prior) and analgesics (6 h prior) prior to any test occasion.  
This study comprised of two Parts (Part I and Part II). One participant completed both Part I 
and Part II of this study. The purpose of Part I was to demonstrate a proof of principle that 
TENS and IFC are able to attenuate EIP. Part II was subsequently conducted to ascertain 
whether the reduction in EIP from TENS and IFC would elicit an improvement in endurance 
exercise performance. The two separates Parts of this study were necessary because where 
interventions to reduce pain during self-paced exercise have been previously used (e.g. Mauger 
et al. 2010), participants usually appear to moderate their work rate in order to maintain the 
same linear progression of EIP. Thus is the current study, Part I provided an exercise task that 
could demonstrate a reduction of perceived EIP as a result of the intervention, which could 
then be directly attributed to any potential performance effect during whole body exercise in 
Part II. As both parts of this study followed a repeated measures design, all participants 







Participants and experimental design: Eighteen recreationally active male (n= 11) and female 
(n= 7) participants were recruited for Part I of this study. Sample size was estimated from 
power calculations using a commercially available software package (GPower) and with mean 
and SD data from similar exercise and pain studies (Mauger et al. 2010; Foster et al. 2014). 
The SDUWLFLSDQWV¶PHDQDJHKHLJKWbody mass, and peak biceps flexion force were 25 ± 6 yrs, 
176 ± 11 cm and 73.5 ± 16.6 kg, 200 ± 65 N respectively. Participants attended the laboratory 
on four occasions (a familiarisation visit and three experimental conditions) at the same time 
of day (± 2 h) to help control for potential circadian influence on psychological variables 
pertinent to this study (Gobbo and Falciati, 2014). The first laboratory visit provided a 
familiarisation (FAM) of all experimental procedures to reduce learning effects, and this was 
followed by three further visits that involved a TENS intervention, an IFC intervention and a 
placebo controlled condition (SHAM). TENS, IFC and SHAM were completed in a single-
blind, randomised and placebo controlled design. 
 
Familiarisation (FAM): Participants were initially tested for sensory discrimination using a 
sharp and blunt patella hammer, and a skin integrity test to ensure normal skin sensation. 
Following this, participants underwent a full familiarisation of TENS and IFC, which also 
provided confirmation for subsequent experimental visits that the applied current intensity 
elicited a tingling sensation without muscle contraction and/or muscle pain (i.e. non-painful 
paraesthesia). During stimulation, and after testing, participants were monitored for signs of 
skin irritation, nausea, swelling and pain. Following this, participants were introduced to 
standard instructions for the numeric perceived pain rating scale (Cook et al. 1997) and rating 
of perceived exertion (RPE) using the Borg (6-20) (Borg, 1998) scale. Participants were 
instructed to report RPE solely as effort to drive the limb (Pageaux et al. 2015) (i.e. independent 
of pain and discomfort) and that pain should be anchored to exercise-induced pain (i.e. numeric 
values given relative to their experience of muscle pain). After participants confirmed their 
understanding of the pain and RPE scales, participants were familiarised with performing a 





Application of TENS, IFC and SHAM: Prior to electrode placement and in order to reduce 
electrical resistance, the skin over the biceps of the dominant arm was cleaned thoroughly. 
Following this, bipolar surface electrodes were attached to the belly of the biceps of the 
dominant arm 2.5 cm apart. This location was marked so that the placement would remain 
consistent between visits. Using a Vectra Genisys multi-waveform stimulator (Chattanooga 
Group, Hixon, TN, USA) the parameters of biphasic IFC pulses were delivered in a continuous 
mode with a pulse frequency of 100 Hz. For the biphasic TENS pulses, a continuous pattern of 
VWLPXODWLRQZDVXVHGZLWKDSXOVHZLGWKRIȝVDQGDIUHTXHQF\RI+]$ELSRODU,)&
set-up was used in the current study in order to maintain blinding of conditions. Both bipolar 
and quadripolar IFC have been shown to be equally successful when used to manage pain 
conditions (Salisbury & Johnson, 1995). The current intensity for the TENS and IFC conditions 
were selected so that participants reached a strong but appropriate intensity without causing 
any noticeable muscle contraction. Stimulation was applied for 5 min prior to, and throughout 
the TTE test and during the pre- and post MVC. A SHAM stimulation was used as a placebo-
controlled condition. During the SHAM condition, electrodes were placed in the same locations 
as the IFC and TENS conditions, but participants received no FXUUHQWDQGZHUHWROG³7KLVW\SH
of stimulation is supposed to reduce pain by using a subthreshold stimulus that you will not 
able to perFHLYH´ 7KLV H[SODQDWLRQ ZDV VWUHQJWKHQHG YLD D YLVXDO GLVSOD\ RI WKH HOHFWULcal 
current on an oscilloscope. 
  
Maximal Voluntary Contraction (MVC): In order to ensure that maximal effort was given 
during the TTE, and that muscle fatigue occurred as a result, an MVC was completed prior to, 
and immediately after completion of the TTE test. The pre-MVC test also served to set the 
target force for the TTE test on that experimental visit. Following a warm-up, participants 
performed three unilateral (dominant arm) maximal voluntary contractions (MVC) of the 
elbow flexors against a load cell (Globus Ergo Meter, Globus, Codogne, Italy), which were 
separated by 3 min rest. To do this, participants were in a seated position with the upper arm 
resting on a bench and the elbow angle at 90º and the wrist angle at 180º. Arm angles for the 
MVC and TTE tests were measured using a goniometer and participant body position was 
maintained both during the tests and between visits by standardising the sitting position for 
each participant. Each MVC test was performed for 5 s with a rapid increase in force over 1 s, 
a sustained maximum for 3 s, and a gradual release over the final second. Maximal force was 
recorded for each MVC. Participants were strongly encouraged to perform maximally 
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throughout each contraction. The maximum of the three values was used to establish the 20% 
MVC for the time to exhaustion task (TTE) performed in that visit. On completion of the TTE 
task, participants performed a final, single MVC.  
 
Time to Exhaustion (TTE) test: A rest period of 10-min was provided after the pre-MVCs. 
Following this, participants undertook the TTE in the same standardised seated position 
described for the MVC tests. The TTE task required the participant to maintain a 20% isometric 
MVC of the biceps until the force dropped for 2 s, or when the participant withdrew from the 
task. During the TTE task, participants were asked to rate their perceived pain and RPE every 
30 s. The experimenter provided no encouragement and sat out of sight from the participants.  
In visits 2-4, participants completed a pre-MVC, followed by the TTE test and a post MVC 
immediately after, with either TENS, IFC or SHAM stimulation being applied during the TTE.  
 
Part II 
Participants and experimental design: Twenty-two participants (male n=14, female n=8), 
trained in cycling or triathlon and exercising regularly (>3 h per week) were recruited for this 
study. Sample size was estimated with a commercially available software package (GPower) 
and with mean and SD data from similar exercise and pain studies (Mauger et al. 2010; Foster 
et al. 2014). 7KHSDUWLFLSDQWV¶PHDQDJHKHLJKW and body mass, VO2max, and peak power output 
were 33 ± 8 yrs, 173 ± 7 cm, 71.8 ± 13.3 kg, 53 ± 7 ml/min/kg, and 286 ± 75 (W), respectively. 
Participants attended the laboratory on four occasions at the same time of day (± 2 h) to 
complete a full familiarisation (FAM) of all experimental procedures, two experimental visits 
(TENS and IFC) and a placebo controlled condition (SHAM). TENS, IFC and SHAM were 
completed in a single-blind, randomised and counter-balanced design.  
 
Familiarisation: On the first visit to the laboratory, participants underwent the same screening, 
stimulation and perceptual scale familiarisations described in Part I. Following this, 
participants completed a graded exercise test (GXT) to exhaustion. Following a 30 min 
recovery period, participants completed a 10 mile (16.1 km) cycling time trial (TT) as fast as 
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they could in order to provide a familiarisation of this task for the subsequent three 
experimental visits. 
 
Graded Exercise Test (GXT): Following a standardized 10-min warm-up at a self-selected 
intensity on the cycle ergometer (Velotron, Racermate, Seattle, WA), participants completed 
an incremental step protocol to exhaustion. Power output (PO) started at 100 W with increases 
of 30 W. min-2, and participants maintained a self-selected cadence until volitional exhaustion 
or when they could no longer maintain the required cadence. During the test, gas exchange 
(Cortex Metalyser 3B, Cortex GmbH, Lepzig, Germany) and heart rate (HR) (Polar Electro, 
N2965, Finland) were recorded continuously, with RPE and perceived pain recorded at the end 
of each stage. Throughout the test verbal encouragement was given by the researcher. On 
completion of the test, participants received a 30 min rest period during which they were 
familiarised with, and completed, a mood questionnaire (Brunel Universal Mood States 
(BRUMS)) (Terry et al. 2003)). 
 
Ten mile time trial (TT): In order to provide a measure of endurance performance, participants 
were instructed to complete a 10-mile (16.1-km) cycling time trial (TT) on the cycle ergometer 
(Velotron, Racermate, Seattle, WA) in the fastest possible time. Participants could change gear 
and cadence to vary their PO, and they could see the distance they had completed but were 
given no information on performance or physiological parameters (e.g. PO, HR, time elapsed). 
Participants were asked to report RPE and perceived pain every km completed. A fingertip 
sample of blood was acquired every 4 km for analysis of blood lactate concentration (B[La]).  
 
TENS, IFC and SHAM stimulation: TENS, IFC and SHAM were applied in visits 2-4. The 
same stimulation parameters and procedures described in Part I were also used for Part II. 
However, stimulation was applied to the belly of the vastus lateralis of both thighs, rather than 
the biceps. To assess potential differences in mood at baseline between conditions, and 
following the TT, a BRUMS was completed on entry to the laboratory and following 




Data and statistical analysis: Prior to statistical analysis, standard assumptions were checked 
for each statistical test, and none of these were violated. Time to exhaustion (TTE) and TT 
completion time were analysed using a repeated measures ANOVA and Bonferroni Pairwise 
Comparisons. Main effect and interaction effects for EIP, RPE, B[La], PO, HR were assessed 
using three-way ANOVA with repeated measures, with follow-up paired samples t-tests used 
to detect differences between conditions when an interaction effect had been observed. All 
statistical analysis was performed using the statistical package SPSS version 22 for Windows. 







Time to Exhaustion (TTE): ANOVA revealed a significant difference in the time to exhaustion 
between conditions (F (2, 34) = 6.763, P = 0.003), as shown in Figure 1a. Pairwise comparisons 
revealed a significantly different TTE time between TENS (10 min 49 s ± 6 min 16 s) and 
SHAM conditions (7 min 52 s ± 2 min 51 s) (P = 0.31) and between IFC (11 min 17 s ± 6 min 
23 s) and SHAM conditions (P = 0.02). No significant difference between TENS and IFC 
conditions was observed (P > 0.05). 
 
Exercise-induced pain (EIP): A 3 x 8 ANOVA revealed a significant main effect of condition 
for perceived exercise-induced pain (F (1.24, 19.13) = 8.39, P = 0.006). There was also a significant 
main effect for time (P < 0.001). There was also a significant interaction effect for exercise-
induced pain over time between conditions during the TTE test (F (3.73, 63.4) = 4.95, P = 0.002), 
as shown in Figure 1b. Follow-up paired-sample t-tests showed a significantly different pain 
perception between TENS and SHAM conditions at 120 s (t (17) = 2.482, P = 0.024), 180 s (t 
(17) = 2.319, P = 0.033), 210 s (t (17) = 3.402, P = 0.003) and 240 s (t (17) = 3.589, P = 0.002. 
Significant differences were also shown between IFC and SHAM conditions at 120 s (t (17) = 
2.482, P = 0.024), 150 s (t (17) = 2.388, P = 0.029), 180 s (t (17) = 2.997, P = 0.008), 210 s (t (17) 
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= 3.298, P = 0.004) and 240 s (t (17) = 2.858, P = 0.011). No differences were found at any time 
point between TENS and IFC conditions (P > 0.05). 
 
Rating of Perceived Exertion (RPE): There was no significant main effect of condition (F (2, 34) 
= 2.71, P = 0.081) for RPE. There was a main effect for time (P < 0.001).  No interaction 
effects for RPE during the TTE were observed (F (4.08, 69.39) = 1.82, P = 0.134). 
 
Maximal Voluntary Contraction (MVC): No significant differences between conditions were 
found for the pre-MVC (F (1.4, 23.4) = 1.758, P = 0.188) or the post-MVC (F (2, 34) = 1.499, P = 
0.238). MVC was significantly reduced following the TTE in the SHAM (t (17) = 9.069, P < 
0.001), TENS (t (17) = 7.037, P < 0.001) and IFC conditions (t (17) = 8.558, P < 0.001), as shown 
in Figure 1d, suggesting that significant fatigue and performance decrement had occurred in all 
conditions following the TTE task.  
 
Part II 
Time Trial (TT) completion time: ANOVA revealed a significant difference in completion time 
between conditions (F (2, 42) = 6.597, P = 0.003). Pairwise comparisons revealed that 
participants performed a significantly faster TT (P = 0.001) in the TENS condition (29 min 6 
s ± 3 min 20 s) compared to the SHAM (29 min 39 s ± 3 min 34 s) condition. There were no 
significant differences (P = 0.872) between the IFC condition (29 min 28 s ± 3 min 34 s) and 
the SHAM, or the TENS and IFC conditions (P = 0.116).  
 
Power Output (PO): ANOVA revealed a significant main effect of condition for power output 
(F (2, 38) = 3.48, P = 0.041). There was also a main effect for distance completed (P < 0.001), 




Rating Perceived Exertion (RPE): No significant main effects for condition were observed (P 
> 0.05). There was a main effect for distance completed (P < 0.001), but no significant 
interaction effect was found (P > 0.05).  
 
Exercise-induced pain (EIP): There was no main effect of condition for EIP (F (1.41, 29.62) = 3.60, 
P = 0.054). There was a significant main effect for distance completed (P < 0.001) and a 
significant interaction effect (F (30, 630) = 2.04, P = 0.001). Follow-up paired t-tests revealed that 
participants perceived significantly less EIP in the TENS condition compared to the SHAM at 
the 4th, 6th, 9th, 11th, 12th, 13th and 15th km (P < 0.05), as shown in Figure 2b. 
 
Heart Rate (HR): ANOVA revealed a significant difference in the mean HR between 
conditions during the TT (F (1.38, 29.06) = 4.016, P = 0.042). There was a significant main effect 
for distance completed (P < 0.05), and a significant interaction effect was observed (F (1.3, 27.8) 
= 3.171, P = 0.008). Follow-up paired-sample t-tests showed a significant difference in HR 
between TENS and SHAM conditions between the 8th-16th km (P < 0.05). Additionally, 
significant differences in HR between IFC and SHAM conditions were observed between the 
11th-16th km (P < 0.05). There were also significant differences in HR between TENS and IFC 
conditions during the 9th, 14th, 15th and 16th km (P < 0.05). Differences in HR between 
conditions are shown in Figure 2c. 
 
Blood lactate B[La]: ANOVA revealed a significant main effect of condition (F (1.49, 31.37) = 
7.54, P = 0.004), a main effect for distance completed (P < 0.05) and a significant interaction 
effect F (3.68, 77.63) = 3.51, P = 0.013). Follow up paired-sample t-tests showed a significantly 
different B[La] between TENS and SHAM conditions at the 12th km (t (21) = - 2.850, P = 0.01), 
and the 16th km (t (21) = - 4.370, P < 0.001). There was also a difference in B[La] between IFC 
and SHAM conditions at the 16th km (t (21) = - 3.632, P = 0.002), and a significant difference 
in B[La] between TENS and IFC conditions at the 12th km (t (21) = 2.496, P = 0.021), as shown 




BRUMS: No differences in mood states were found between conditions pre- or post TT. Paired-
sample t-tests showed a significant difference for vigour from pre- to post TT during the TENS 





This study investigated whether TENS and IFC can moderate EIP, and whether this would lead 
to an improvement in endurance performance. The primary finding was that both TENS and 
IFC were able to significantly reduce EIP during single limb exercise, but only TENS was 
capable improving whole-body endurance performance. This is the first study utilising a 
randomised, crossover and placebo controlled design, which shows an ergogenic effect for 
TENS. This study also provides support for the notion that EIP is a limiter of endurance 
performance in both single limb and whole-body exhaustive exercise. Although pain tolerance 
has long been linked to athletic potential (Scott and Gijsbers, 1981), it is only relatively recently 
that a growing body of empirical evidence has provided strong support this notion. EIP may 
exacerbate fatigue by reducing voluntary activation of the muscle (Kennedy et al. 2013) or by 
contributing to a host of unpleasant sensations (Kress and Stratler, 2007) that either leads to a 
decision to reduce work rate or disengage with the task (Mauger, 2014). Whilst the current 
study cannot identify whether psychological or physiological determinants led to the apparent 
ergogenic effect of therapeutic muscle stimulation, it does provide further evidence that 
analgesic interventions during exercise can improve endurance performance. 
In both Parts of the study, EIP increased as function of time and reached its most intense at the 
end of the exercise, where near maximal values were observed. To moderate this pain, without 
changing the metabolic environment at the muscle, TENS and IFC were used to inhibit the 
transmission of the nociceptive signal at the spinal level. The TENS intervention appeared to 
reduce perceived pain, which resulted in a longer time to exhaustion of the sustained isometric 
contraction and a faster TT time. The analgesic mechanism of TENS and IFC are suggested to 
be underpinned by the gate-control theory of pain (Sluka & Walsh, 2003). Indeed, when TENS 
and IFC are applied to produce a strong comfortable and non-painful paraesthesia, large 
diameter afferents (A-beta fibres) are selectively activated (Sluka & Walsh, 2003). The 
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activation of these large diameter low threshold mechano-receptive nerve fibres could inhibit 
the nociceptive transmission from small diameter higher threshold nociceptive (A-delta and C) 
fibres through pre and post synaptic inhibition in the dorsal horn of the spinal cord (Melzack 
& Wall, 1967). This would reduce the number of nociceptive signals reaching the higher brain 
centres and consequently reduce the perceived pain for a given stimulus at the nociceptor. A 
reduction in the afferent barrage from Type III and IV fibres could also offset the reduction in 
voluntary activation that is observed during painful exercise (Kennedy et al. 2013), which 
would likely allow for an improved exercise performance. Analgesia through TENS and IFC 
may also be explained by the release of endogenous opioids (Sabino et al. 2008). Whilst 
evidence for this mechanism is stronger for low frequency TENS (Sjölund & Eriksson, 1979), 
more recent studies on animal models also suggest that analgesia by high frequency TENS is 
UHGXFHGE\V\VWHPLFQDOR[RQHLQKLJKHQRXJKGRVHWREORFNȝįDQG țRSLRLGUHFHStors (Han 
et al.1991), thus supporting a role for endogenous opioids for both high and low frequency 
TENS. The observation that IFC only provided an analgesic advantage in single limb exercise 
is contrary to what was expected, and difficult to reconcile. The most likely reason is that whilst 
TENS is suggested to primarily operate according to Gate Control Theory, IFC involves 
modulation of the transmission of pain through the release of endogenous opioids (Sabino et 
al. 2008). Ray and Carter (2007) have previously shown that endogenous opioids do not appear 
to modulate acute EIP, and so the lack of analgesic effect of IFC could be explained by it 
primarily operating through this mechanism.  
 
The mean reduction in perceived pain (compared to the SHAM condition) elicited by TENS 
was approximately 12% during single-limb exercise, with a stronger effect evident later in the 
exercise (>30% after 180 s ± see Figure 1b). The greater reductions in pain towards the end of 
exercise are paralleled by the increasingly noxious environment in the muscle and the 
consequential increased pain (Cook et al., 1997). Therefore, the apparent analgesic effect of 
the stimulation was most noticeable during a noxious environment that elicited a pain intensity 
RI a µ6RPHZKDW VWURQJ SDLQ¶ DQG DERYH RQ WKH &RRN 6FDOH (Cook et al. 1997). It is 
important to note that in the familiarisation visits, this scale was anchored specifically 
according to previously experienced maximum and minimum levels of muscle pain during 
exercise, rather than a general pain sensation (e.g. dental pain), so as to provide a measure 
specific to the experiences of EIP. The effectiveness of the analgesia observed in the current 
study is supported by some studies which have used TENS to reduce pain. Indeed, in a cross-
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over study investigating neuropathic pain in patients with spinal cord injury, analgesic TENS 
was shown to elicit a 29-38% improvement on a global relief scale. Furthermore, Bjordal et al. 
(2003) demonstrated a 26.5% mean reduction in analgesic consumption for post-operative 
patients following a well-controlled TENS intervention. Salisbury and Johnson (1995) have 
also shown that TENS increased the cold pain threshold and that IFC decreased cold pain 
intensity. However, whilst several studies have demonstrated positive analgesic effects of 
TENS, there are a number of studies that show no such effect (Johnson & Tabasam, 1998; 
Claydon et al. 2008; Gomes et al. 2014). The numerous systematic reviews and meta-analysis 
(Zeng et al., 2015) on this area suggest that different TENS parameters, patient groups, 
outcome measures and a lack of placebo controls and randomisation are the reason for the 
equivocal findings for the effectiveness of TENS. Therefore, in the current study the use of a 
placebo controlled condition, the randomisation of conditions and the controlled exercise 
intensity between conditions and participants presents a robust experimental design that 
supports the effectiveness of TENS as an analgesic intervention, and a role for EIP in endurance 
performance. 
 
A notable observation in the current study is that endurance performance improved following 
a reduction in pain, but with no significant change in RPE between conditions. It has been 
suggested that RPE is the conscious manifestation of afferent information from a host of 
afferent physiological systems and external cues, and that this perception of effort is an 
important determinant of endurance performance (Tucker, 2009). However, there is strong 
evidence to suggest that the primary generator for perception of effort is the corollary discharge 
(i.e. an internal signal that arises from centrifugal motor commands) associated with central 
motor command (McCloskey, 1981), and that this is independent from afferent feedback 
(including pain) from the working muscles and other interoceptors (de Morree et al. 2014). 
Indeed, feelings of pain and discomfort have often been assessed as part of the perception of 
effort (Noble & Robertson, 1996), although numerous studies have shown that pain and effort 
can be dissociated (Cook et al. 1997; Pageaux et al. 2015; Angius et al. 2015; Astokorki & 
Mauger, 2016) and are therefore distinct entities. By dissociating perception of effort and EIP 
in the current study, we were able to observe the individual effects of therapeutic muscle 
stimulation on EIP and RPE, and the consequent impact on endurance performance. In-line 
with our hypothesis, a reduction in EIP paralleled an improvement in TTE and TT performance. 
This finding supports the view that EIP is a contributing factor to task cessation and self-paced 
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performance (Mauger, 2014), but is contrary to the view that endurance performance is 
primarily determined by perception of effort, as stated by the Psychobiological Model 
(Marcora, 2010). Although this model acknowledges that severe pain (such as that from a 
muscle strain) would affect motivation (and therefore inhibit performance), it suggests that the 
muscle pain normally experienced during high-intensity aerobic exercise does not limit 
performance in healthy humans (Marcora, 2010). The results of the current study suggest that 
µQRUPDO¶(,3H[SHULHnced during exhaustive exercise does affect performance and that it can 
be moderated independently of perception of effort. These findings support other studies which 
demonstrate that an analgesic intervention is able to improve exercise performance in a variety 
of exercise models (Mauger et al. 2010; Foster et al. 2014) and strengthens the notion (Kress 
& Statler, 2007) that tolerance of EIP is an important prerequisite for endurance performance 
(Mauger, 2013, Mauger, 2014). 
 
CONCLUSION 
In conclusion, the findings of this study suggest that TENS can elicit an analgesic effect on EIP 
during both an exhaustive single limb, submaximal isometric contraction and in whole-body 
exercise. Reducing pain during this exercise improved endurance performance, without any 
changes WRSDUWLFLSDQWV¶SHUFHSWLRQRIeffort. Further studies are needed to identify how TENS 
or IFC elicits an analgesic effect for EIP, and the psychophysiological mechanisms 
underpinning the subsequent improvement in endurance performance. 
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Figure 1. Performance and perceptual differences between conditions in Part I. Panel A shows 
the TTE differences between conditions. Panel B shows exercise-induced pain intensity over 
time between conditions during the TTE test. Panel C shows the differences in mean exercise-
induced pain intensity between conditions over the TTE test. Panel D shows maximal voluntary 
contraction values for pre- and post TTE test between conditions. *significant difference (P < 
0.05).  **significant difference between IFC and SHAM (P < 0.05). # significant difference 
between TENS and SHAM (P < 0.05). $ main effect for condition (P < 0.05).  
 
Figure 2. Performance, physiological and perceptual differences between conditions over time 
during the time trial in Part II. Panel A shows the power output differences between conditions 
over time. Panel B shows exercise-induced pain intensity over time between conditions. Panel 
C shows heart rate values between conditions. Panel D shows the blood lactate concentration 
between conditions. # significant difference between TENS and SHAM (P < 0.05). ** 
significant difference between IFC and SHAM (P < 0.05).  § significant difference between 
TENS and IFC (P < 0.05). $ main effect for condition (P < 0.05).  
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